News updates

Guillain-Barré Syndrome after COVID-19 vaccination

Until October 12th 2022, the Netherlands Pharmacovigilance Centre Lareb received 72 reports of  Guillain-Barré Syndrome (GBS) following COV...

Propylthiouracil and ANCA vasculitis

The Netherlands Pharmacovigilance Centre Lareb received seven well-documented reports on propylthiouracil and anti-neutrophil cytoplasmic antibody (ANCA)...

Call for abstracts for the ISoP Mid-Year Symposium 2023

This year the ISoP mid-year meeting will be hosted by the Netherlands Pharmacovigilance Centre Lareb on 1-2 June 2023 in Leiden, the N...

Higher probability of experiencing a side effect in women after COVID-19 vaccination

Females have a two-fold higher odds of experiencing an adverse event following immunization (AEFI) than m...